In vitro dissolution and in vivo gamma scintigraphic evaluation of press-coated salbutamol sulfate tablets

1. N. Nidni, Chronotherapeutics - a chronopharmaceutical approach to drug delivery in the treatment of asthma, J. Control. Release 163 (2012) 353-360; DOI: 10.1016/j.jconrel.2012.09.012.10.1016/j.jconrel.2012.09.012Search in Google Scholar

2. K. P. Pagar and P. R. Vavia, Felodipine b-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension, Acta Pharm. 62 (2012) 395-410; DOI: 10.2478/ v10007-012-0023-0.10.2478/v10007-012-0023-0Search in Google Scholar

3. L. ShanYang and K. Yoshiaki, Current status and approaches to developing press-coated chronodelivery drug systems, J. Control. Release 157 (2012) 331-353; DOI: 10.1016/j.jconrel.2011.09.065.10.1016/j.jconrel.2011.09.065Search in Google Scholar

4. M. Ghimire, F. J. McInnes, D. G. Watson, A. B. Mullen and H. N. E. Stevens, In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: A pharmacoscintigraphic study in the beagle dog, Eur. J. Pharm. Biopharm. 67 (2007) 515-523.10.1016/j.ejpb.2007.03.002Search in Google Scholar

5. G. P. Andrews, D. S. Jones, O. A. Diak, C. P. McCoy, A. B. Watts and J. W. McGinity, The manufacture and characterisation of hot-melt extruded enteric tablets, Eur. J. Pharm. Biopharm. 69 (2008) 264-273; DOI: 10.1016/j.ejpb.2007.11.001.10.1016/j.ejpb.2007.11.001Search in Google Scholar

6. T. Yoshihiro, O. Hiroyuki and O. Makoto, Non-invasive and rapid analysis for observation of internal structure of press-coated tablet using X-ray computed tomography, Drug. Dev. Ind. Pharm. 35 (2009) 678-682; DOI: 10.1080/03639040802587807.10.1080/03639040802587807Search in Google Scholar

7. H. W. Kelly and S. Murphy, Beta-adrenergic agonists for acute, severe asthma, Ann. Pharmacother. 26 (1992) 81-91.10.1177/106002809202600115Search in Google Scholar

8. C. Xiaoyu, H. Wenhua, W. Blenda Chi, Y. Linlin, W. Yuen Fan, X. Min and Y. Zhijun, Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery, Int. J. Nanomedicine 7 (2012) 1139-1148; DOI: 10.2147/IJN.S28011.10.2147/IJN.S28011Search in Google Scholar

9. A. Paratchikody, V. V. Prasanth, S. T. Mathew and B. A. Kumar, Development and characterization of mucoadhesive patches of salbutamol sulfate for unidirectional buccal drug delivery, Acta Pharm. 61 (2011) 157-170; DOI: 10.2478/v10007-011-0011-9.10.2478/v10007-011-0011-9Search in Google Scholar

10. W. Jing, C. Ping, L. Qiuhua, L. Sanming, W. Ling and Z. Xiangrong, Development and evaluation of press-coated salbutamol sulfate tablets for delayed-release dosage forms, J. Drug Del. Sci. Tech. 22 (2012) 335-334.10.1016/S1773-2247(12)50056-0Search in Google Scholar

11. H. N. Stevens, C. G. Wilson, P. G. Welling, M. Bakhshaee, J. S. Binns, A. C. Perkins, M. Frier, E. P. Blackshaw, M. W. Frame, D. J. Nichols, M. J. Humphrey and S. R. Wicks, Evaluation of Pulsincap to provide regional delivery of dofetilide to the human GI tract, Int. J. Pharm. 236 (2002) 27-34.10.1016/S0378-5173(02)00012-1Search in Google Scholar